newsletter

Subscribe to the newsletter

news

Expanding Advanced Circulatory Support portfolio with TandemLife acquisition

The TandemLife platform also includes a family of unique cannulae that can provide unmatched versatility and designed to meet the needs of the most demanding mechanical cardiac support (MCS) programs

TandemLife,  manufacturer of Advanced Circulatory Support (ACS) devices, percutaneous Mechanical Circulatory Support (MCS) and Extracorporeal Life Support (ECLS) products, is now part of LivaNova PLC.   The acquisition effectively extends LivaNova’s reach into ACS with temporary cardiopulmonary support capabilities.
 
The  demand for Advanced Circulatory Support (ACS) solutions continues to grow and technological advancements designed to increase ease of use and patient safety are essential to support the growth in the hospitals that wish to access these procedures.  The TandemLife platform also includes a family of unique cannulae that can provide unmatched versatility and are designed to meet the needs of the most demanding mechanical cardiac support (MCS) programs
 
ProtekDuo is the only percutaneous dual lumen cannula that can be inserted at the Right Internal Jugular vein and is uniquely positioned to source venous blood from the right atrium and return it to the pulmonary artery.  ProtekDuo delivers flexibility to do what’s right for each unique patient.
 
The ProtekSolo Transseptal cannula provides unique cannula positioning, sourcing oxygenated blood from the left atrium, bypassing the left ventricle.  Sourcing blood from the left atrium enables left ventricle decompression and consistent unloading throughout the cardiac cycle.
 
The overall versatility of the TandemLife  platform effectively enriches LivaNova’s cardiopulmonary-focused product mix and will help to further the advancement of ACS, reaching more patients in more places.

IM-02402